Aortic valve replacement with homograft and autograft.
The aortic valve may be replaced with an aortic homograft or a pulmonary autograft in children and young adults. The risk of surgery is low (2.5%). No anticoagulants are required, and thromboembolism is virtually unknown unless valve degeneration or endocarditis occur. Late follow-up indicates that approximately 85% of patients will be free of reoperation at 10 years when an aortic homograft is used and at 20 years when a pulmonary autograft is used.
Doty
D B
DB
Department of Surgery, LDS Hospital, Salt Lake City, UT, USA.
D000328:Adult; D000925:Anticoagulants; D001021:Aortic Valve / Q000601:surgery / Q000637:transplantation*; D002648:Child; D004697:Endocarditis, Bacterial / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000209:etiology; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011664:Pulmonary Valve / Q000637:transplantation*; D012086:Reoperation; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000925:Anticoagulants